EcoDrugPlus

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSCVAG00000008656
Gene Symbol: LOC107098287
3 Cross references
200 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSCVAG00000013524
Gene Symbol: LOC107101261
2 Cross references
195 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1-Like

Ensembl ID : ENSCVAG00000003163
Gene Symbol: LOC107096196
3 Cross references
192 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1-Like

Ensembl ID : ENSCVAG00000009576
Gene Symbol: LOC107102649
3 Cross references
188 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSCVAG00000015885
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSCVAG00000017559
Gene Symbol: DPYD
3 Cross references
217 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSCVAG00000010641
Gene Symbol: DDR2
3 Cross references
205 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSCVAG00000000684
Gene Symbol: DDR2
1 Cross references
189 Possible Orthologues:

Disintegrin And Metalloproteinase Domain-Containing Protein 17-Like

Ensembl ID : ENSCVAG00000011267
Gene Symbol: LOC107087577
3 Cross references
209 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSCVAG00000013353
Gene Symbol: DRD1
3 Cross references
188 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSCVAG00000004929
Gene Symbol: DRD1B
1 Cross references
199 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSCVAG00000018086
Gene Symbol: DRD2
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).